Operating Expenses 更改
Adcock Ingram Holdings ZAR 3.91B 168.42M 2023-06
Celltrion KRW 73.04B 294.4B 2024-03
Cspc Pharmaceutical CNY 5.8B 34.94M 2023-12
Dianthus Therapeutics USD 18.72M 5.3M 2024-03
Ecofibre AUD 19.41M 20.67M 2023-06
Eli Lilly USD 6.03B 933.2M 2024-03
Kangmei Pharma CNY 1.26B 82.83M 2024-03
Knight Therapeutics CAD 83.94M 707K 2024-03
Laboratorios Farma EUR 131.89M 181.99M 2024-03
Malin Corporation EUR 2.2M 800K 2023-06
Medical Developments International AUD 29.84M 359K 2023-06
Neuren Pharmaceuticals AUD 14.78M 6.84M 2023-06
Organigram Holdings CAD 52.6M 221K 2024-03
Pacira USD 152M 3.93M 2024-03
Perrigo USD 1.09B 76.3M 2024-03
Pharma Mar EUR 42.3M 3.33M 2024-03
Probiotec AUD 99.23M 4.08K 2023-06
Qiagen NV USD 360.55M 38M 2024-03
Sartorius EUR 697.2M 32.6M 2024-03
Sino Biopharmaceutical CNY 11.53B 892.53M 2023-06
Supernus Pharmaceuticals USD 147.89M 17.42M 2024-03
Tilray USD 221.71M 13.82M 2024-02
Zz Pientze Pharmaceu 1.52B 25.23M 2023-09



Xeris Pharmaceuticals 营业费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.